凤凰网首页 手机凤凰网

凤凰卫视
  • [亚太] 上证指数 2319.12 (1.00%) 深证成指 9466.14 1.78% 恒生指数 19664.10 -1.06% 台北 7233.69 0.17% 韩国 1964.83 0.39%
  • [亚太] 日经 8841.22 -0.09% 澳大利亚 4348.48 0.45% 新西兰 3294.64 0.40% 印度孟买 17234.00 0.92% 新加坡 2916.26 0.75%
  • [美洲] 道琼斯 12660.50 -0.58% 纳斯达克 2816.55 0.40% 标普500 1316.33 -0.16% 加拿大 12466.50 0.02% 巴西 62904.20 -0.08%
  • [欧洲] 英国富时 5733.45 -1.07% 法国CAC 3318.76 -1.32% 德国DAX 6511.98 -0.43% 俄罗斯 1508.04 -0.44% Stoxx50 2436.62 -0.97%
  • [其他] 纽约原油 99.70 0.00% 纽约黄金 1738.40 0.00% 人民币/美元 6.33 0.00% 美元指数 78.83 0.00% 基金指数 3782.30 1.37%
  • [亚太] 上证指数 2319.12 (1.00%) 深证成指 9466.14 1.78% 恒生指数 19664.10 -1.06% 台北 7233.69 0.17% 韩国 1964.83 0.39%
  • [亚太] 日经 8841.22 -0.09% 澳大利亚 4348.48 0.45% 新西兰 3294.64 0.40% 印度孟买 17234.00 0.92% 新加坡 2916.26 0.75%
  • [美洲] 道琼斯 12660.50 -0.58% 纳斯达克 2816.55 0.40% 标普500 1316.33 -0.16% 加拿大 12466.50 0.02% 巴西 62904.20 -0.08%
  • [欧洲] 英国富时 5733.45 -1.07% 法国CAC 3318.76 -1.32% 德国DAX 6511.98 -0.43% 俄罗斯 1508.04 -0.44% Stoxx50 2436.62 -0.97%
  • [其他] 纽约原油 99.70 0.00% 纽约黄金 1738.40 0.00% 人民币/美元 6.33 0.00% 美元指数 78.83 0.00% 基金指数 3782.30 1.37%
免费注册
华兰生物(002007)公告正文

华兰生物工程股份有限公司2006年第三季度季度报告全文

公告日期 2006-10-26
股票简称:华兰生物 股票代码:002007

        华兰生物工程股份有限公司2006年第三季度季度报告全文

    §1  重要提示
    1.1  本公司董事会、监事会及董事、监事、高级管理人员保证本报告所载资料不存在任何虚假记载、误导性陈述或者重大遗漏,并对其内容的真实性、准确性和完整性承担个别及连带责任。
    公司全体董事、高级管理人员已对本报告内容的真实性、准确性、完整性签署书面确认意见,监事会已审核了本报告内容的真实性、准确性、完整性并签署了书面审核意见。
    1.2  没有董事、监事、高级管理人员对季度报告内容的真实性、准确性、完整性无法保证或存在异议。
    1.3  所有董事均出席董事会
    1.4  本报告期财务报告未经审计
    1.5  公司负责人安康先生、主管会计工作负责人王启平先生及会计机构负责人(会计主管人员)桑莉女士声明:保证季度报告中财务报告的真实、完整。
    §2  公司基本情况
    2.1  公司基本信息


━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
  股票简称                华兰生物                                                                                     
  股票代码                002007                                                                                       
  上市证券交易所          深圳证券交易所                                                                               
                          董事会秘书                       证券事务代表                投资者关系管理负责人            
  姓名                    范蓓                             /                           安康                            
  联系地址                河南省新乡市华兰大道甲1号        /                           河南省新乡市华兰大道甲1号       
  电话                    0373-3519901                     /                           0373-3519901                    
  传真                    0373-3519911                     /                           0373-3519911                    
  电子信箱                hualan@hualanbio.com             /                           hualan@hualanbio.com            
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
2.2  财务资料
    2.2.1  主要会计数据及财务指标
    单位:(人民币)元


━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
                          2006年9月30日                      2005年12月31日                     增减幅度(%)         
  总资产                  769,702,386.47                     699,992,855.66                     9.96%                  
  股东权益(不含少数股东  540,253,207.33                     526,226,054.29                     2.67%                  
  权益)                                                                                                               
  每股净资产              5.376                              5.236                              2.67%                  
  调整后的每股净资产      5.370                              5.234                              2.60%                  
                          2006年7-9月            比上年同期增减(%)     2006年1-9月            比上年同期增减(%)    
  主营业务收入            87,955,348.62          2.67%                   264,449,068.94         1.95%                  
  净利润                  23,644,364.07          29.91%                  64,126,289.91          56.07%                 
  经营活动产生的现金流量  11,618,207.19          -49.84%                 24,470,486.83          -68.43%                
  净额                                                                                                                 
  每股收益                0.235                  29.83%                  0.638                  55.99%                 
  每股收益(注)          0.157                  -                       0.425                  -                      
  净资产收益率            4.38%                  0.84%                   11.87%                 3.89%                  
  扣除非经常性损益后的净  4.60%                  1.06%                   12.20%                 4.18%                  
  资产收益率                                                                                                           
  非经常性损益项目            金额                                                                                     
  营业外收支净额              -4,304,557.20                                                                            
  财政贴息                    1,580,000.00                                                                             
  补贴收入                    646,494.89                                                                               
  所得税的影响数              311,709.35                                                                               
  合计                        -1,766,352.96                                                                            
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
注1:如果报告期末至报告披露日,公司股本发生变化的,按新股本计算
    
    2.2.2  财务报表
    2.2.2.1  资产负债表
    编制单位:华兰生物工程股份有限公司            2006年9月30日            单位:(人民币)元


━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
  项目                    期末数                                         上年度末数                                    
                          合并                   母公司                  合并                   母公司                 
  流动资产:                                                                                                           
  货币资金                183,645,097.49         142,492,099.34          199,053,202.77         152,651,188.91         
  短期投资                                                                                                             
  应收票据                7,284,721.20           7,235,721.20            14,254,294.04          12,336,754.04          
  应收股利                                                                                                             
  应收利息                                                                                                             
  应收账款                62,954,976.53          60,345,867.03           55,525,516.50          52,541,387.90          
  其他应收款              10,762,760.69          10,586,089.43           6,691,663.10           6,598,608.96           
  预付账款                96,211,327.10          89,906,882.58           103,970,025.91         60,563,617.61          
  应收补贴款                                                                                                           
  存货                    91,846,397.93          81,122,418.78           100,931,576.53         86,463,186.91          
  待摊费用                96,796.78              96,796.78               165,058.16             165,058.16             
  一年内到期的长期债权投                                                                                               
  资                                                                                                                   
  其他流动资产                                                                                                         
  流动资产合计            452,802,077.72         391,785,875.14          480,591,337.01         371,319,802.49         
  长期投资:                                                                                                           
  长期股权投资            28,500,000.00          107,401,037.26          4,275,000.00           83,990,834.21          
  长期债权投资                                                                                                         
  长期投资合计            28,500,000.00          107,401,037.26          4,275,000.00           83,990,834.21          
  合并价差                                                                                                             
  固定资产:                                                                                                           
  固定资产原价            239,632,360.81         155,622,293.50          220,842,295.56         153,718,865.01         
  减:累计折旧            68,221,385.60          63,005,704.66           61,144,006.29          59,953,138.75          
  固定资产净值            171,410,975.21         92,616,588.84           159,698,289.27         93,765,726.26          
  减:固定资产减值准备                                                                                                 
  固定资产净额            171,410,975.21         92,616,588.84           159,698,289.27         93,765,726.26          
  工程物资                                                                                                             
  在建工程                101,745,469.30         109,695,466.53          39,524,604.48          47,474,601.71          
  固定资产清理                                                                                                         
  固定资产合计            273,156,444.51         202,312,055.37          199,222,893.75         141,240,327.97         
  无形资产及其他资产:                                                                                                 
  无形资产                15,243,864.24          10,184,506.19           15,903,624.90          10,762,223.21          
  长期待摊费用                                                                                                         
  其他长期资产                                                                                                         
  无形资产及其他资产合计  15,243,864.24          10,184,506.19           15,903,624.90          10,762,223.21          
  递延税项:                                                                                                           
  递延税款借项                                                                                                         
  资产总计                769,702,386.47         711,683,473.96          699,992,855.66         607,313,187.88         
  流动负债:                                                                                                           
  短期借款                115,000,000.00         85,000,000.00           24,000,000.00                                 
  应付票据                996,301.68             996,301.68              3,629,275.00           3,629,275.00           
  应付账款                29,214,281.19          25,910,823.97           43,809,877.64          38,406,172.22          
  预收账款                1,358,906.65           1,253,726.65            2,488,463.45           1,661,663.45           
  应付工资                1,000.00                                       1,000.00                                      
  应付福利费              11,188,785.74          11,188,785.74           11,320,336.87          11,320,336.87          
  应付股利                20,857,500.00          20,857,500.00                                                         
  应交税金                6,621,828.70           6,367,515.85            7,984,213.25           8,035,584.98           
  其他应交款              3,668.68                                       148.20                                        
  其他应付款              11,781,118.17          11,715,612.74           47,785,916.72          9,894,101.07           
  预提费用                                                               37,200.00                                     
  预计负债                                                                                                             
  一年内到期的长期负债                                                                                                 
  其他流动负债                                                                                                         
  流动负债合计            197,023,390.81         163,290,266.63          141,056,431.13         72,947,133.59          
  长期负债:                                                                                                           
  长期借款                                                                                                             
  应付债券                                                                                                             
  长期应付款                                                                                                           
  专项应付款              8,140,000.00           8,140,000.00            8,140,000.00           8,140,000.00           
  其他长期负债                                                                                                         
  长期负债合计            8,140,000.00           8,140,000.00            8,140,000.00           8,140,000.00           
  递延税项:                                                                                                           
  递延税款贷项                                                                                                         
  负债合计                205,163,390.81         171,430,266.63          149,196,431.13         81,087,133.59          
  少数股东权益            24,285,788.33                                  24,570,370.24                                 
  所有者权益(或股东权益                                                                                               
  ):                                                                                                                 
  实收资本(或股本)      100,500,000.00         100,500,000.00          100,500,000.00         100,500,000.00         
  减:已归还投资                                                                                                       
  实收资本(或股本)净额  100,500,000.00         100,500,000.00          100,500,000.00         100,500,000.00         
  资本公积                276,771,732.03         276,771,732.03          276,620,868.90         276,620,868.90         
  盈余公积                26,558,065.83          26,558,065.83           26,558,065.83          26,558,065.83          
  其中:法定公益金                                                                                                     
  未分配利润              136,423,409.47         136,423,409.47          122,547,119.56         122,547,119.56         
  其中:现金股利                                                         50,250,000.00          50,250,000.00          
  未确认的投资损失                                                                                                     
  外币报表折算差额                                                                                                     
  所有者权益(或股东权益  540,253,207.33         540,253,207.33          526,226,054.29         526,226,054.29         
  )合计                                                                                                               
  负债和所有者权益(或股  769,702,386.47         711,683,473.96          699,992,855.66         607,313,187.88         
  东权益)合计                                                                                                         
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
法定代表人:安康                主管会计机构负责人:王启平            会计机构负责人:桑莉
    2.2.2.2  本报告期利润及利润分配表
    编制单位:华兰生物工程股份有限公司             2006年7—9月             单位:(人民币)元


━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
  项目                    本期                                           上年同期                                      
                          合并                   母公司                  合并                   母公司                 
  一、主营业务收入        87,955,348.62          83,476,528.19           85,670,395.59                                 
  减:主营业务成本        49,267,213.55          44,604,784.08           51,167,311.04                                 
  主营业务税金及附加      12,205.47                                                                                    
  二、主营业务利润(亏损  38,675,929.60          38,871,744.11           34,503,084.55                                 
  以“-”号填列)                                                                                                      
  加:其他业务利润(亏损  120,067.59             120,067.59              337,801.78                                    
  以“-”号填列)                                                                                                      
  减:营业费用            6,261,754.42           6,260,843.42            10,760,468.08                                 
  管理费用                4,007,139.88           3,478,861.93            2,726,398.49                                  
  财务费用                1,030,354.44           723,381.24              -60,810.53                                    
  三、营业利润(亏损以“  27,496,748.45          28,528,725.11           21,414,830.29                                 
  -”号填列)                                                                                                          
  加:投资收益(亏损以“                         -777,359.52                                                           
  -”号填列)                                                                                                          
  补贴收入                646,494.89             646,494.89                                                            
  营业外收入              31,195.90              31,195.90               2,624.00                                      
  减:营业外支出          2,185,686.56           2,185,686.56            4,680.00                                      
  四、利润总额(亏损以“  25,988,752.68          26,243,369.82           21,412,774.29                                 
  -”号填列)                                                                                                          
  减:所得税              2,610,110.53           2,599,005.75            3,211,916.15                                  
  少数股东损益            -265,721.92                                                                                  
  加:未确认的投资损失本                                                                                               
  期发生额                                                                                                             
  五、净利润(亏损以“-   23,644,364.07          23,644,364.07           18,200,858.14                                 
  ”号填列)                                                                                                           
  加:年初未分配利润      112,779,045.40         112,779,045.40          100,774,083.28                                
  其他转入                                                                                                             
  六、可供分配的利润      136,423,409.47         136,423,409.47          118,974,941.42                                
  减:提取法定盈余公积                                                                                                 
  提取法定公益金                                                                                                       
  提取职工奖励及福利基金                                                                                               
  提取储备基金                                                                                                         
  提取企业发展基金                                                                                                     
  利润归还投资                                                                                                         
  七、可供投资者分配的利  136,423,409.47         136,423,409.47          118,974,941.42                                
  润                                                                                                                   
  减:应付优先股股利                                                                                                   
  提取任意盈余公积                                                                                                     
  应付普通股股利                                                                                                       
  转作资本(或股本)的普                                                                                               
  通股股利                                                                                                             
  八、未分配利润          136,423,409.47         136,423,409.47          118,974,941.42                                
  利润表(补充资料)                                                                                                   
  1.出售、处置部门或被                                                                                                
  投资单位所得收益                                                                                                     
  2.自然灾害发生的损失                                                                                                
  3.会计政策变更增加(                                                                                                
  或减少)利润总额                                                                                                     
  4.会计估计变更增加(                                                                                                
  或减少)利润总额                                                                                                     
  5.债务重组损失                                                                                                      
  6.其他                                                                                                              
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
法定代表人:安康                主管会计机构负责人:王启平            会计机构负责人:桑莉
    2.2.2.3  年初到报告期末利润及利润分配表
    编制单位:华兰生物工程股份有限公司             2006年1—9月             单位:(人民币)元


━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
  项目                    年初到报告期末                                 上年同期                                      
                          合并                   母公司                  合并                   母公司                 
  一、主营业务收入        264,449,068.94         246,370,973.59          259,399,786.12                                
  减:主营业务成本        153,100,543.32         136,762,328.47          174,207,535.15                                
  主营业务税金及附加      30,646.46                                                                                    
  二、主营业务利润(亏损  111,317,879.16         109,608,645.12          85,192,250.97                                 
  以“-”号填列)                                                                                                      
  加:其他业务利润(亏损  91,475.94              91,475.94               969,760.83                                    
  以“-”号填列)                                                                                                      
  减:营业费用            19,338,126.98          19,233,395.98           25,800,232.65                                 
  管理费用                14,286,951.52          12,568,522.47           11,096,885.94                                 
  财务费用                252,382.62             -626,506.26             712,705.27                                    
  三、营业利润(亏损以“  77,531,893.98          78,524,708.87           48,552,187.94                                 
  -”号填列)                                                                                                          
  加:投资收益(亏损以“                         -814,796.95                                                           
  -”号填列)                                                                                                          
  补贴收入                646,494.89             646,494.89                                                            
  营业外收入              173,407.72             173,407.72              2,649.00                                      
  减:营业外支出          4,569,899.79           4,569,899.79            214,511.75                                    
  四、利润总额(亏损以“  73,781,896.80          73,959,914.74           48,340,325.19                                 
  -”号填列)                                                                                                          
  减:所得税              9,940,188.80           9,833,624.83            7,251,048.79                                  
  少数股东损益            -284,581.91                                                                                  
  加:未确认的投资损失本                                                                                               
  期发生额                                                                                                             
  五、净利润(亏损以“-   64,126,289.91          64,126,289.91           41,089,276.40                                 
  ”号填列)                                                                                                           
  加:年初未分配利润      122,547,119.56         122,547,119.56          104,685,665.02                                
  其他转入                                                                                                             
  六、可供分配的利润      186,673,409.47         186,673,409.47          145,774,941.42                                
  减:提取法定盈余公积                                                                                                 
  提取法定公益金                                                                                                       
  提取职工奖励及福利基金                                                                                               
  提取储备基金                                                                                                         
  提取企业发展基金                                                                                                     
  利润归还投资                                                                                                         
  七、可供投资者分配的利  186,673,409.47         186,673,409.47          145,774,941.42                                
  润                                                                                                                   
  减:应付优先股股利                                                                                                   
  提取任意盈余公积                                                                                                     
  应付普通股股利          50,250,000.00          50,250,000.00           26,800,000.00                                 
  转作资本(或股本)的普                                                                                               
  通股股利                                                                                                             
  八、未分配利润          136,423,409.47         136,423,409.47          118,974,941.42                                
  利润表(补充资料)                                                                                                   
  1.出售、处置部门或被                                                                                                
  投资单位所得收益                                                                                                     
  2.自然灾害发生的损失                                                                                                
  3.会计政策变更增加(                                                                                                
  或减少)利润总额                                                                                                     
  4.会计估计变更增加(                                                                                                
  或减少)利润总额                                                                                                     
  5.债务重组损失                                                                                                      
  6.其他                                                                                                              
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
法定代表人:安康               主管会计机构负责人:王启平             会计机构负责人:桑莉
    2.2.2.4  年初到报告期末现金流量表
    编制单位:华兰生物工程股份有限公司             2006年1-9月             单位:(人民币)元


━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
  项目                                           年初到报告期末                                                        
                                                 合并                                母公司                            
  一、经营活动产生的现金流量:                                                                                         
  销售产品、提供劳务收到的现金                   307,614,517.89                      285,306,485.05                    
  收到的税费返还                                 1,712,218.46                        526,494.89                        
  收到的其他与经营活动有关的现金                 2,737,238.83                        2,462,649.96                      
  现金流入小计                                   312,063,975.18                      288,295,629.90                    
  购买商品、接受劳务支付的现金                   194,720,796.31                      183,917,925.25                    
  支付给职工以及为职工支付的现金                 11,340,735.22                       10,336,454.19                     
  支付的各项税费                                 46,017,406.06                       43,783,755.97                     
  支付的其他与经营活动有关的现金                 35,514,550.76                       30,592,472.26                     
  现金流出小计                                   287,593,488.35                      268,630,607.67                    
  经营活动产生的现金流量净额                     24,470,486.83                       19,665,022.23                     
  二、投资活动产生的现金流量:                                                                                         
  收回投资所收到的现金                                                                                                 
  取得投资收益所收到的现金                                                                                             
  处置固定资产、无形资产和其他长期资产所收回的   110,000.00                          110,000.00                        
  现金净额                                                                                                             
  收到的其他与投资活动有关的现金                                                                                       
  现金流入小计                                   110,000.00                          110,000.00                        
  购建固定资产、无形资产和其他长期资产所支付的   66,857,733.14                       62,298,320.83                     
  现金                                                                                                                 
  投资所支付的现金                               24,225,000.00                       24,225,000.00                     
  支付的其他与投资活动有关的现金                 10,344,770.00                                                         
  现金流出小计                                   101,427,503.14                      86,523,320.83                     
  投资活动产生的现金流量净额                     -101,317,503.14                     -86,413,320.83                    
  三、筹资活动产生的现金流量:                                                                                         
  吸收投资所收到的现金                                                                                                 
  借款所收到的现金                               115,000,000.00                      85,000,000.00                     
  收到的其他与筹资活动有关的现金                                                                                       
  现金流入小计                                   115,000,000.00                      85,000,000.00                     
  偿还债务所支付的现金                           24,000,000.00                                                         
  分配股利、利润或偿付利息所支付的现金           29,557,922.25                       28,407,624.25                     
  支付的其他与筹资活动有关的现金                                                                                       
  现金流出小计                                   53,557,922.25                       28,407,624.25                     
  筹资活动产生的现金流量净额                     61,442,077.75                       56,592,375.75                     
  四、汇率变动对现金的影响                       -3,166.72                           -3,166.72                         
  五、现金及现金等价物净增加额                   -15,408,105.28                      -10,159,089.57                    
  现金流量表补充资料                                                                                                   
  1.将净利润调节为经营活动现金流量:                                                                                  
  净利润                                         64,126,289.91                       64,126,289.91                     
  加:计提的资产减值准备                         -559,345.78                         -478,346.41                       
  固定资产折旧                                   14,880,753.30                       10,855,939.90                     
  无形资产摊销                                   605,064.90                          577,717.02                        
  长期待摊费用摊销                                                                                                     
  待摊费用减少(减:增加)                       68,261.38                           68,261.38                         
  预提费用增加(减:减少)                                                                                             
  处置固定资产、无形资产和其他长期资产的损失(   73,423.82                           73,423.82                         
  减:收益)                                                                                                           
  固定资产报废损失                               4,274,264.92                        4,274,264.92                      
  财务费用                                       2,286,857.58                        1,250,341.72                      
  投资损失(减:收益)                                                               814,796.95                        
  递延税款贷项(减:借项)                                                                                             
  存货的减少(减:增加)                         9,817,291.37                        6,072,880.90                      
  经营性应收项目的减少(减:增加)               -50,102,266.32                      -52,368,810.66                    
  经营性应付项目的增加(减:减少)               -20,715,526.34                      -15,601,737.22                    
  其他                                                                                                                 
  少数股东损益                                   -284,581.91                                                           
  经营活动产生的现金流量净额                     24,470,486.83                       19,665,022.23                     
  2.不涉及现金收支的投资和筹资活动:                                                                                  
  债务转为资本                                                                                                         
  一年内到期的可转换公司债券                                                                                           
  融资租入固定资产                                                                                                     
  3.现金及现金等价物净增加情况:                                                                                      
  现金的期末余额                                 183,645,097.49                      142,492,099.34                    
  减:现金的期初余额                             199,053,202.77                      152,651,188.91                    
  加:现金等价物期末余额                                                                                               
  减:现金等价物期初余额                                                                                               
  现金及现金等价物净增加额                       -15,408,105.28                      -10,159,089.57                    
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
法定代表人:安康               主管会计机构负责人:王启平             会计机构负责人:桑莉
    2.3  股本变动和股东持股情况
    2.3.1  报告期末股东总人数及前十名无限售条件流通股股东持股情况表


━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
  报告期末股东总数                   6,134                                                                             
  前十名无限售条件流通股股东持股情况                                                                                   
  股东名称(全称)                   期末持有无限售条件流通股的数量          种类(A、B、H股或其它)                   
  中国工商银行-国联安德盛小盘精选   4,000,000.00                            A股                                       
  证券投资基金                                                                                                         
  汉盛证券投资基金                   3,965,679.00                            A股                                       
  中国工商银行-安信证券投资基金     3,402,013.00                            A股                                       
  中国建设银行-中小企业板交易型开   3,159,272.00                            A股                                       
  放式指数基金                                                                                                         
  中国工商银行-汉鼎证券投资基金     1,809,590.00                            A股                                       
  上海慧恒投资有限公司               1,230,000.00                            A股                                       
  中国工商银行-德盛稳健证券投资基   1,057,335.00                            A股                                       
  金                                                                                                                   
  华夏成长证券投资基金               1,052,458.00                            A股                                       
  交通银行-泰达荷银价值优化型成长   900,000.00                              A股                                       
  类行业证券投资基金                                                                                                   
  中国银行-海富通股票证券投资基金   891,200.00                              A股                                       
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
2.3.2  报告期内限售股份持有人持股变动情况


━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
                              限售股份持有人持股总数(1  限售股份持有人所持有限售条件股  限售股份持有人所持无限售条件  
                              )=(2)+(3)             份数量(2)                     股份数量(3)                 
  期初数                      55,629,760                 55,629,760                      0                             
  本期增加                    0                          0                               0                             
  本期减少                    0                          0                               0                             
  期末数                      55,629,760                 55,629,760                      0                             
  持股变动情况说明            报告期内,公司限售股份持有人严格遵守《上市公司股权分置改革管理办法》、《中小企业板上市公  
                              司限售股份上市流通实施细则》等规定、公司章程以及在股权分置改革过程中做出的承诺。         
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
§3  管理层讨论与分析
    3.1  公司报告期内经营活动总体状况的简要分析


━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
  2006年7-9月份,公司实现主营业务收入8,795.53万元,主营业务利润3,867.59万元,净利润2,364.44万元,分别比去年同期增长2.6 
  7%、12.09%和29.91%。2006年1-9月份,公司累计实现主营业务收入26,444.91万元、主营业务利润11,131.79万元、净利润6,412.63  
  万元,分别比上年同期增长1.95%、30.67%和56.07%。                                                                      
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
3.1.1  占主营收入或主营业务利润总额10%以上的主营行业或产品情况
    √ 适用 □ 不适用 
    单位:(人民币)万元


━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
  主营业务分行业情况                                                                                                   
                          主营业务收入               主营业务成本                主营业务利润率(%)                  
  生物药品制造业          8,795.54                   4,926.72                    43.99%                                
  主营业务分产品情况                                                                                                   
  人血白蛋白              6,332.66                   3,380.50                    46.62%                                
  静注丙球                1,123.96                   659.80                      41.30%                                
  其他                    1,338.92                   886.42                      33.80%                                
  其中:关联交易          0.00                       0.00                        0.00%                                 
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
3.1.2  公司经营的季节性或周期性特征
    □ 适用 √ 不适用 
    3.1.3  报告期利润构成情况(主营业务利润、其他业务利润、期间费用、投资收益、补贴收入与营业外收支净额在利润总额中所占比例与前一报告期相比的重大变动及原因的说明)
    □ 适用 √ 不适用 
    3.1.4  主营业务及其结构与前一报告期相比发生重大变化的情况及原因说明
    □ 适用 √ 不适用 
    3.1.5  主营业务盈利能力(利润率)与前一报告期相比发生重大变化的情况及其原因说明
    □ 适用 √ 不适用 
    3.2  重大事项及其影响和解决方案的分析说明
    √ 适用 □ 不适用 


━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
  1.开展投资者关系管理的具体情况:公司重视投资者关系管理工作,由公司董事长安康先生担任投资者关系管理负责人,在安康先  
  生的领导下公司证券部平时主要通过电话、传真、电子邮件等方式回答广大投资者的咨询,使其及时了解公司生产经营情况。2.其  
  他重大事项及其影响和解决方案的分析说明:2006年8月18日,公司二届十六次董事会审议通过了《2006年半年度资本公积金转增股  
  本的预案》,即以2006年6月30日公司总股本10050万为基数,用资本公积金向全体股东每10转增5股,该方案于2006年10月10日经公  
  司2006年第一次临时股东大会审议通过,2006年10月20日转增股本事宜实施完毕。                                             
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
3.3  会计政策、会计估计、合并范围变化以及重大会计差错的情况及原因说明
    □ 适用 √ 不适用 
    3.4  经审计且被出具“非标意见”情况下董事会和监事会出具的相关说明
    □ 适用 √ 不适用 
    3.5  对2006年度经营业绩的预计
    单位:(人民币)元


━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
  对2006年度经营业绩的预  净利润比上年增长30%以上                                                                      
  计                      公司预计2006年净利润比上年增长30%-60%。                                                      
  上年经营业绩            净利润                 52,542,887.69                                                         
                          每股收益               0.52                                                                  
  业绩变动的原因说明      1、公司主导产品人血白蛋白平均价格上涨。2、公司小制品销售比重提升,血浆综合利用率提高。       
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
3.6  公司对已披露的年度经营计划或预算的滚动调整情况
    □ 适用 √ 不适用 
    3.7  原非流通股东在股权分置改革过程中做出的特殊承诺及其履行情况
    √ 适用 □ 不适用 


━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
  股东名称             特殊承诺                                                                  承诺履行情况          
  全体原非流通股东     若华兰生物2005年度经审计后的净利润较2004年增长低于20%时或者华兰生物2005   未达到履约条件        
                       年度财务报告被出具非标准无保留意见审计报告时,触发追送股份承诺条款:由原                         
                       非流通股股东将其执行对价安排后的存量股份中的165万股(相当于按照股权分置                         
                       改革前流通股3300万股每10股追送0.5股)向无限受条件的流通股股东追送股份。                         
  全体原非流通股东     在实施股权分置改革方案之后,将向2005年度股东大会提出如下分红议案,并保证   严格履行承诺          
                       在股东大会表决时对该议案投赞成票:华兰生物2005年度的利润分配比例将不低于                        
                       2005年度实现的可分配利润(非累计可分配利润)的70%。                                               
  新乡市华兰生物技术   自改革方案实施之日起,至少在十二个月内不上市交易或者转让,并在该期限届满  严格履行承诺          
  有限公司             后12个月内,若通过深圳证券交易所交易系统出售华兰生物股票,出售价格不低于                        
                       12.25元。同时,当华兰生物派发红股、转增股本、增资扩股(包括可转换债券转                         
                       换的股本)、配股、派息等情况使股份数量或股东权益发生变化时,相应调整最低                        
                       出售价格(2005年度分红派息和2006年中期转增股本后,上述价格调整为7.83元)。                         
  北京东方世辰生物技   自改革方案实施之日起,至少在十二个月内不上市交易或者转让,并在该期限届满  严格履行承诺          
  术有限公司           后24个月内,通过证券交易所挂牌交易出售股份,出售数量占其所持有本公司股份                        
                       总数的比例,在每季度不超过百分之二十。                                                          
  成都夸常科技有限公   自改革方案实施之日起,至少在十二个月内不上市交易或者转让,并在该期限届满  严格履行承诺          
  司                   后24个月内,通过证券交易所挂牌交易出售股份,出售数量占其所持有本公司股份                        
                       总数的比例,在每季度不超过百分之二十。                                                          
  新乡市纪龙广告有限   自改革方案实施之日起,至少在十二个月内不上市交易或者转让,并在该期限届满  严格履行承诺          
  公司                 后24个月内,通过证券交易所挂牌交易出售股份,出售数量占其所持有本公司股份                        
                       总数的比例,在每季度不超过百分之二十。                                                          
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
3.8  非经营性资金占用及清欠情况
    □ 适用 √ 不适用 
    3.9  募集资金项目进展缓慢的情况说明
    □ 适用 √ 不适用 
数据加载中...
prevnext
手机查看股票